All In Biotech

Free tool

FAERS Monitor: Comtan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020796 or its brand name (Comtan, Entacapone). Reports on generic versions are filed under their own applications.

Reports

4,252

Serious

3,020

71% of reports

Hospitalization

1,451

Death reported

653

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hallucination509
  • fall493
  • dyskinesia491
  • drug ineffective356
  • death353
  • parkinson^s disease289
  • confusional state279
  • gait disturbance273
  • tremor273
  • on and off phenomenon259
  • somnolence208
  • fatigue207
  • constipation201
  • dizziness199
  • nausea198

Reports by year received

View as table
YearReports
200422
200518
200620
200731
200858
200936
201079
201168
201257
201355
201481
2015105
2016141
2017333
2018333
2019375
2020390
2021409
2022391
2023277
2024317
2025378
2026277

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,907 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
on and off phenomenonSignal259242.0214.459,054
dyskinesiaSignal49160.555.628,371
hallucinationSignal50933.631.016,030
confusional stateSignal2798.67.61,865
tremorSignal2738.17.31,716
fallSignal4937.36.82,731
gait disturbanceSignal2737.16.31,426
somnolenceSignal2085.14.5690
constipationSignal2014.64.0561
deathSignal3532.01.8190
dizziness1992.01.797
drug ineffective3561.31.232
fatigue2071.31.216
nausea1981.21.19
parkinson^s disease2890.00.01,425,793

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.